Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
Primaquine phosphate is an oral small-molecule antimalarial approved in 1952 for the treatment and prevention of malaria, particularly effective against Plasmodium vivax and Plasmodium ovale. It is the only FDA-approved drug capable of eliminating hypnozoites (dormant liver stage parasites), making it essential for radical cure and prevention of relapse. The drug works by generating reactive oxygen species within malaria parasites, leading to their destruction.
With LOE approaching and minimal Part D spending ($9K in 2023), the brand team is small and focused on niche malaria markets with limited growth trajectory.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
Primaquine Enantiomers in G6PD Deficient Human Volunteers
Phase 2 Efficacy Study of Primaquine and Methylene Blue
Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Worked on PRIMAQUINE at Sanofi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on primaquine offers a career in specialized infectious disease markets with deep expertise in malaria treatment and tropical medicine, but with limited growth and promotional opportunity due to the product's mature, generic-competitive lifecycle. Roles focus on niche geographic markets and healthcare partnerships in endemic regions rather than broad commercial expansion.